Autres langues Recce Pharmaceuticals Ltd

Actions

RCE

AU000000RCE5

Marché Fermé - Australian S.E. Autres places de cotation 08:10:43 01/05/2024			Varia. 5j.	Varia. 1 janv.
0,66 ^AUD	0,00 %		+1,54 %	+23,36 %

17/04	Recce Pharmaceuticals Ltd. achève la production de 5 000 doses hebdomadaires de RECCE 327 selon les bonnes pratiques de fabrication	CI
04/04	Recce Pharmaceuticals Ltd reçoit un nouveau brevet en Israël pour les anti-infectieux Recce	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Recce Pharmaceuticals Announces Safety Committee Approves High Dose of 4,000mg in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis	30/04
Recce Pharmaceuticals Ltd. Announces Safety Committee Approves High Dose of 4,000mg in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis	30/04
Recce Pharmaceuticals Completes 5,000 RECCE® 327 Doses a Week under Good Manufacturing Practice (GMP)	17/04
Recce Pharmaceuticals Ltd. Completes 5,000 RECCE 327 Doses Week Under Good Manufacturing Practice	17/04
Recce Pharmaceuticals Ltd.: Recce stellt 5.000 Dosen RECCE® 327 pro Woche nach der Guten Herstellungspraxis (GMP) her	16/04
Recce Pharmaceuticals Advances Production of Anti-Infective Medication	16/04
Recce Pharmaceuticals Provides Business Update	10/04
Recce Pharmaceuticals Ltd.: Recce Pharmaceuticals von der Innovationsagentur der Regierung des Vereinigten Königreichs für die Teilnahme an der AMR-Mission 2024 ausgewählt	10/04
Recce Pharmaceuticals Selected by UK Government Innovation Agency to Participate in AMR Mission 2024	10/04
Recce Pharmaceuticals Ltd.: Recce Pharmaceuticals (ASX:RCE, FWB:R9Q) Business Update	08/04
Recce Pharmaceuticals Granted New Patent in Israel for RECCE® Anti-Infectives	04/04
Recce Pharmaceuticals Ltd Receives New Patent in Israel for Recce Anti-Infectives	04/04
Recce Pharmaceuticals Secures Israeli Patent for Anti-Infective Medication; Shares Rise 5%	03/04
Recce Pharmaceuticals Announces RECCE® Trademark Registered in Canada, Strengthening Global IP Portfolio	22/03
Recce Pharmaceuticals Secures Canadian Trademark for Antibiotic Medications	21/03
Recce Pharmaceuticals Completes Dosing Cohort in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis	19/03
Recce Pharmaceuticals Completes Dosing Cohort in Phase I/II Trial of Recce® 327 for Urinary Tract Infections and Urosepsis	19/03
Recce Pharmaceuticals Ltd.: Klinische Phase-I/II-Studie zur Schnellinfusion bei Harnwegsinfektionen/Urosepsis: Kohortenverabreichung wurde abgeschlossen	15/03
Recce Pharmaceuticals Concludes Cohort Dosing in Synthetic Anti-Infectives Trial	15/03
Recce Pharmaceuticals Doses Next Cohort in Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis	14/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Recce Pharmaceuticals Ltd

Actions

RCE

AU000000RCE5

Autres langues

Filtres